بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

لايوجد

الموقع الشخصى
السيرة الذاتية

نورا جمال محمد عبدالله عيسى

الكلية الصيدلة - القسم الصيدلانيات

الدرجات العلمية

بكالوريوس فى الصيدلانيات, -جامعة الزقازيق [2005]
ماجستير فى الصيدلانيات, -جامعة الزقازيق [2010]
(صياغة و تقييم لبعض الاشكال الصيدلية التي تلتصق علي الاغشية المطاطية)
دكتوراه فى الصيدلانيات, -CARDIFF [2016]

الحالة الوظيفية الحالية :

معار

التدرج الوظيفى الأكاديمى

معيد : 3/10/2005
مدرس مساعد : 23/1/2011
مدرس : 26/4/2016
أستاذ مساعد : 22/3/2022
استاذ مساعد لقب علمى : 22/3/2022

الأبحاث العلمية

1 - Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides (1435).

2 - Buccoadhesive tablets for delivery of verapamil Hcl: Design, in-vitro analysis and in-vivo evaluation (1433).

3 - Fast disintegrating tablet of Doxazosin Mesylate nanosuspension: Preparation and characterization (1442).

4 - Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study (1440).

5 - Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs (1442).

6 - New approach for administration of doxazosin mesylate: comparative study between liquid and solid self-nanoemulsifying drug delivery systems (1442).

7 - Morphologic design of sugar-based polymer nanoparticles for delivery of antidiabetic peptides (1442).

8 - Intratracheal administration of chloroquine-loaded niosomes minimize systemic drug exposure (1443).

9 - Development of Potent Nanosized Isatin-isonicotinohydrazide Hybrid for Management of Mycobacterium Tuberculosis (1443).

10 - EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide (1441).

11 - Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations (1443).

12 - Niosomal and ethosomal gels: A comparative in vitro and ex vivo evaluation for repurposing of spironolactone (1444).

13 - Methods for preparation of nanostructured lipid carriers (1443).

14 - Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors (1444).

15 - Morphologic design of nanostructures for enhanced antimicrobial activity (1444).

16 - Design of Nanoconstructs that Exhibit Enhanced Hemostatic Efficiency and Bioabsorbability (1443).

17 - Nanomaterials and immune system (1443).

18 - Methods for preparation of niosomes: A focus on thin-film hydration method (1443).

19 - Brain-targeted delivery of Valsartan using solid lipid nanoparticles labeled with Rhodamine B; a promising technique for mitigating the negative effects of stroke (1444).

20 - Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control (1444).

21 - Intranasal thermosensitive hydrogel of agomelatine solid dispersion for better management of depression (1445).

22 - Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain (1445).

23 - Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs (1445).

24 - Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: Effect on ocular retention and intraocular pressure (1445).

25 - Machine learning algorithms for prediction of entrapment efficiency in nanomaterials (1445).

26 - Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain (1445).

27 - In vitro and in vivo studies of Syzygium cumini-loaded electrospun PLGA/PMMA/collagen nanofibers for accelerating topical wound healing (1445).

28 - Electrospun Tamarindus indica-loaded antimicrobial PMMA/cellulose acetate/PEO nanofibrous scaffolds for accelerated wound healing: in-vitro and in-vivo assessments (1445).

29 - Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes (1445).

30 - Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems (1445).

31 - Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems (1445).

32 - 24 Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation. (1445).

33 - Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes (1445).

المجالات البحثية

Enhancing the Delivery of Therapeutic Cargo to Cancer Cells Using Cell Penetrating Peptides